FusionPharm, Inc. (FSPM)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Sep 3, 2025, 8:00 PM EDT
FusionPharm Market Cap
FusionPharm has a market cap or net worth of $1.26 thousand as of September 5, 2025.
Market Cap
1.26K
Enterprise Value
n/a
Revenue
328.70K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since July 14, 2008, FusionPharm's market cap has decreased from 654.26K to 1.26K, a decrease of -99.81%. That is a compound annual growth rate of -30.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 1.26K | 9,584.62% |
| Dec 31, 2024 | 13.00 | - |
| Dec 26, 2023 | 13.00 | -99.48% |
| Dec 30, 2022 | 2.52K | 100.00% |
| Dec 31, 2021 | 1.26K | -95.46% |
| Dec 31, 2020 | 27.70K | -73.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 840.66M |
| Elite Pharmaceuticals | 760.21M |
| Tian'an Technology Group | 673.67M |
| Glass House Brands | 576.95M |
| CytoDyn | 401.20M |
| Northwest Biotherapeutics | 387.41M |
| American Oncology Network | 352.23M |